Apolipoprotein E Polymorphism Is Associated with Age of Onset and Neuropathology in Colony Stimulating Factor 1 Receptor‐Related Disorder
Movement Disorders · 2026
DOI: 10.1002/mds.70192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Tomasz Chmiela und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Apolipoproteins E, Neurodegenerative Diseases, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Colony stimulating factor 1 receptor–related disorder (CSF1R‐RD) is a rare, rapidly progressive neurodegenerative disease with significant clinical heterogeneity. Apolipoprotein E (ApoE) polymorphism, known to modulate microglial function and influence neurodegeneration, may act as a genetic modifier in CSF1R‐RD.
Objectives
The objectives were to evaluate the distribution of ApoE alleles in CSF1R‐RD and assess their association with clinical and neuropathological features.
Methods
ApoE genotyping was performed in 55 individuals with CSF1R‐RD. Clinical data from 25 deceased patients were analyzed based on ApoE genotype. Neuropathological evaluation was conducted on brain tissue from 14 patients, with semiquantitative scoring of white matter pathology and microglial burden. Statistical comparisons were made between carriers and noncarriers of the ApoE4 allele.
Results
ApoE allele frequencies in CSF1R‐RD mirrored those of the general population (ε2: 7.3%, ε3: 79.1%, ε4: 13.6%). However, ApoE4 carriers exhibited significantly earlier symptom onset (median: 37.9 vs. 50.3 years, p = 0.0123) and death (median: 41.1 vs. 55.2 years, p = 0.0072). Neuropathological analysis revealed more severe white matter involvement and reduced microglial preservation in ApoE4 carriers ( p = 0.034).
Conclusions
Although ApoE allele distribution does not differ from the general population, the presence of the ApoE4 allele may influence the clinical trajectory and white matter pathology in CSF1R‐RD. These findings suggest that ApoE polymorphism is a potential modifier of disease course and should be considered in therapeutic planning and future research. © 2026 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
- Department of Neurology, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland.
- Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
ORCID-Profile: Tomasz Chmiela, Audrey J Strongosky, Dennis W Dickson, Zbigniew K Wszolek
Zitieren
APA
Chmiela, T., Roemer, S., Strongosky, A. J., Baker, M. C., Dickson, D. W., & Wszolek, Z. K. (2026). Apolipoprotein E Polymorphism Is Associated with Age of Onset and Neuropathology in Colony Stimulating Factor 1 Receptor‐Related Disorder. Movement Disorders. https://doi.org/10.1002/mds.70192
Vancouver
Chmiela T, Roemer S, Strongosky AJ, Baker MC, Dickson DW, Wszolek ZK. Apolipoprotein E Polymorphism Is Associated with Age of Onset and Neuropathology in Colony Stimulating Factor 1 Receptor‐Related Disorder. Movement Disorders. 2026. doi:10.1002/mds.70192
BibTeX
@article{Chmiela2026,
author = {Chmiela, Tomasz and Roemer, Shanu and Strongosky, Audrey J and Baker, Matthew C and Dickson, Dennis W and Wszolek, Zbigniew K},
title = {Apolipoprotein E Polymorphism Is Associated with Age of Onset and Neuropathology in Colony Stimulating Factor 1 Receptor‐Related Disorder},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70192}
}
EUVIMED